Trial NCT03844932

View at ClinicalTrials.gov 
Org. Study IDs: CYC-202

Last trial update was posted on 2021-05-07

MeSH Interventions

Cyclosporine Cyclosporins

MeSH Conditions

Colitis Colitis, Ulcerative Ulcer

Other Conditions


Stopping Reasons

The Sublimity Board of Directors carefully evaluated the IA data: the 9.6% treatment remission difference for 75mg BID vs placebo (due to an increase in placebo response rate) was determined not sufficient to continue to fund the study

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID